A Cutting-Edge Cancer Treatment Is Under FDA Investigation—for Cancer Risk

CAR-T cell therapy harnesses the immune system to attack blood cancers. Six years after approving the first treatment, the FDA is investigating whether it can give rise to secondary cancers.

from Feed: All Latest https://ift.tt/ZrfD9Oj
via IFTTT

No comments:

Post a Comment

Amazon Prime Members Can Get Two Free E-Books in August

We may earn a commission from links on this page. Deal pricing and availability subject to change after time of publication. You can get th...